We report that RNASE4 expression is increased progressively in prostate cancer, correlates with aggressiveness of the disease, can accurately distinguish between healthy, BPH, and prostate cancer, and can independently predict biopsy outcome. This evidence concerns the gene RNASE4 and prostate carcinoma.